Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1995 Apr;71(834):198–201. doi: 10.1136/pgmj.71.834.198

Stroke prevention.

R Tozer 1, I R Hastie 1
PMCID: PMC2398072  PMID: 7784274

Full text

PDF
198

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alderman M. H. Blood pressure management: individualized treatment based on absolute risk and the potential for benefit. Ann Intern Med. 1993 Aug 15;119(4):329–335. doi: 10.7326/0003-4819-119-4-199308150-00013. [DOI] [PubMed] [Google Scholar]
  2. Brand F. N., Abbott R. D., Kannel W. B., Wolf P. A. Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study. JAMA. 1985 Dec 27;254(24):3449–3453. [PubMed] [Google Scholar]
  3. Connolly S. J., Laupacis A., Gent M., Roberts R. S., Cairns J. A., Joyner C. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol. 1991 Aug;18(2):349–355. doi: 10.1016/0735-1097(91)90585-w. [DOI] [PubMed] [Google Scholar]
  4. Dahlöf B., Lindholm L. H., Hansson L., Scherstén B., Ekbom T., Wester P. O. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) Lancet. 1991 Nov 23;338(8778):1281–1285. doi: 10.1016/0140-6736(91)92589-t. [DOI] [PubMed] [Google Scholar]
  5. Dennis M., Bamford J., Sandercock P., Warlow C. Prognosis of transient ischemic attacks in the Oxfordshire Community Stroke Project. Stroke. 1990 Jun;21(6):848–853. doi: 10.1161/01.str.21.6.848. [DOI] [PubMed] [Google Scholar]
  6. Ezekowitz M. D., Bridgers S. L., James K. E., Carliner N. H., Colling C. L., Gornick C. C., Krause-Steinrauf H., Kurtzke J. F., Nazarian S. M., Radford M. J. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med. 1992 Nov 12;327(20):1406–1412. doi: 10.1056/NEJM199211123272002. [DOI] [PubMed] [Google Scholar]
  7. Forfar J. C. A 7-year analysis of haemorrhage in patients on long-term anticoagulant treatment. Br Heart J. 1979 Aug;42(2):128–132. doi: 10.1136/hrt.42.2.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gurwitz J. H., Goldberg R. J., Holden A., Knapic N., Ansell J. Age-related risks of long-term oral anticoagulant therapy. Arch Intern Med. 1988 Aug;148(8):1733–1736. [PubMed] [Google Scholar]
  9. Homer A. C., Honavar M., Lantos P. L., Hastie I. R., Kellett J. M., Millard P. H. Diagnosing dementia: do we get it right? BMJ. 1988 Oct 8;297(6653):894–896. doi: 10.1136/bmj.297.6653.894. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kopecky S. L., Gersh B. J., McGoon M. D., Whisnant J. P., Holmes D. R., Jr, Ilstrup D. M., Frye R. L. The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med. 1987 Sep 10;317(11):669–674. doi: 10.1056/NEJM198709103171104. [DOI] [PubMed] [Google Scholar]
  11. Landefeld C. S., Goldman L. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. Am J Med. 1989 Aug;87(2):144–152. doi: 10.1016/s0002-9343(89)80689-8. [DOI] [PubMed] [Google Scholar]
  12. Meyer J. S., Rogers R. L., McClintic K., Mortel K. F., Lotfi J. Randomized clinical trial of daily aspirin therapy in multi-infarct dementia. A pilot study. J Am Geriatr Soc. 1989 Jun;37(6):549–555. doi: 10.1111/j.1532-5415.1989.tb05688.x. [DOI] [PubMed] [Google Scholar]
  13. Petersen P., Boysen G., Godtfredsen J., Andersen E. D., Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet. 1989 Jan 28;1(8631):175–179. doi: 10.1016/s0140-6736(89)91200-2. [DOI] [PubMed] [Google Scholar]
  14. Petersen P., Godtfredsen J. Embolic complications in paroxysmal atrial fibrillation. Stroke. 1986 Jul-Aug;17(4):622–626. doi: 10.1161/01.str.17.4.622. [DOI] [PubMed] [Google Scholar]
  15. Ratcliffe P. J., Wilcock G. K. Cerebrovascular disease in dementia: the importance of atrial fibrillation. Postgrad Med J. 1985 Mar;61(713):201–204. doi: 10.1136/pgmj.61.713.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Wickramasinghe L. S., Basu S. K., Bansal S. K. Long-term oral anticoagulant therapy in elderly patients. Age Ageing. 1988 Nov;17(6):388–396. doi: 10.1093/ageing/17.6.388. [DOI] [PubMed] [Google Scholar]
  17. Wolf P. A., Abbott R. D., Kannel W. B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991 Aug;22(8):983–988. doi: 10.1161/01.str.22.8.983. [DOI] [PubMed] [Google Scholar]
  18. Wolf P. A., Dawber T. R., Thomas H. E., Jr, Kannel W. B. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology. 1978 Oct;28(10):973–977. doi: 10.1212/wnl.28.10.973. [DOI] [PubMed] [Google Scholar]
  19. Wolf P. A., Kannel W. B., McGee D. L., Meeks S. L., Bharucha N. E., McNamara P. M. Duration of atrial fibrillation and imminence of stroke: the Framingham study. Stroke. 1983 Sep-Oct;14(5):664–667. doi: 10.1161/01.str.14.5.664. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES